BEFORE Brands™, Inc. Secures $35 Million in Series B Funding Led by Gurnet Point Capital to Finance Commercial Product Launch

Sigue a La Opinión en Facebook

Industry veterans Christopher Viehbacher and Greg Horn join the Board
of Directors

Early Adaptive Training™ products available to consumers by end of
2017

MENLO PARK, Calif.–(BUSINESS WIRE)–BEFORE Brands™, Inc., a science-based consumer products company
dedicated to bringing innovative, proprietary nutritional products
directly to families, today announced that it has raised $35 million in
private funding in a Series B financing round led by Gurnet Point
Capital. In conjunction with the financing, two new directors will join
the Board: Christopher Viehbacher, the Managing Partner of Gurnet Point
Capital and former CEO of Sanofi S.A., along with Greg Horn, the CEO of
Specialty Nutrition Group, Inc. and former CEO of both GNC Holdings,
Inc. and Garden of Life.

BEFORE Brands products are founded on a growing body of evidence in
support of nutritional strategies that include potentially allergenic
foods as a regular part of a healthy diet. This round of funding will
enable BEFORE Brands to launch its first line of proprietary
dietary supplements including the novel Early Adaptive Training™ protein
blend with Vitamin D later in 2017. These edible products are designed
to be incorporated into the diet of healthy infants beginning around 6
months of age as part of solid food introduction, to give parents the
confidence that their baby is accustomed to a wide variety of foods now
and for the future, along with Vitamin D for immune support. In
addition, the financing will be used to fund medical education on daily
protein training strategies that include foods like peanut and egg as a
consistent part of the diet beginning before age one. The products are
based on insights and intellectual property developed by Dr. Kari
Nadeau, pediatrician and Director of the Sean N. Parker Center for
Allergy and Asthma Research at Stanford University, and licensed to
BEFORE Brands by Stanford University on an exclusive, global basis.

This financing and the addition of Chris and Greg to our Board will
provide both the capital needed to enable our first product rollout and
expand the world-class expertise we can draw upon to commercialize this
novel, important product line,” said Dr. Ashley Dombkowski, BEFORE
Brands’ co-founder and CEO. “We are excited that Gurnet Point Capital
has increased its commitment to our mission by leading the Series B
financing. The team’s healthcare expertise and global footprint have
already proved instrumental to our momentum and we are confident they
will continue to add significant value in our next stage of growth.”

BEFORE Brands was founded to create an entirely new type of product
based on clinical evidence and consumer appeal,” said Chris Viehbacher,
Managing Partner of Gurnet Point Capital. “When we first invested, the
company’s development priority was to deliver a product that would meet
Dr. Nadeau’s exacting technical standards in terms of the specific Early
Adaptive Training™ ingredient blend, protein quality, convenience, and
safety. At the same time, they aspired to bring something to the market
that would be differentiated, easy, accessible, and truly loved by
babies and parents. The team has delivered on that mandate and with this
financing, we are looking forward to the company introducing this new
line to consumers later this year.”

About BEFORE Brands, Inc.

The immune system: part soldier, part sentinel. An essential balance,
perfected by time but increasingly disrupted by modern living. BEFORE
Brands™ is developing edible products to support this critical duality,
beginning in healthy infants before problems arise. Our products use our
proprietary Early Adaptive Training™ blend of whole food proteins &
Vitamin D designed to help provide balanced, gentle & consistent immune
system support right from the start. This technology was innovated by
Dr. Kari Nadeau, a pediatrician, mother of five, and the Director of the
Sean N. Parker Center for Allergy and Asthma Research at Stanford
University. Our products build on a growing body of evidence in support
of nutritional strategies that include potentially allergenic foods as a
regular part of a healthy diet. At BEFORE Brands, We Nourish
Possibilities™. For more information please visit www.beforebrands.com.

About Gurnet Point Capital

Gurnet Point Capital (GPC) is a unique health care fund founded by
Ernesto Bertarelli and led by Christopher A. Viehbacher, who, together,
have decades of expertise in an industry for which they share a passion,
both as Chief Executives and as investors. With an initial allocation of
$2 billion, GPC is investing long-term capital and supporting
entrepreneurs in building a new generation of companies. Based in
Cambridge, MA, its remit is global, encompassing life sciences and
medical technologies. The fund invests across all stages of product
development through to commercialisation and does so with an approach
that is a hybrid of venture and private equity investing strategies.
This approach is governed by a guiding tenet that even the earliest of
technologies must present a clear commercial case, benefiting both
patients and the healthcare system as a whole.

Contacts

BEFORE Brands, Inc.
Dana Cormack, 202-609-6018
dana.cormack@inventivhealth.com
or
Gurnet
Point Capital
Abernathy MacGregor
Tom Johnson, 212-371-5999
tbj@abmac.com
or
Blair
Hennessy, 212-371-5999
bth@abmac.com